Golden Leaf Reports Third Quarter 2017 Results
Nov 29, 2017 21:10 pm UTC| Business
TORONTO, Nov. 29, 2017 -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced its unaudited financial...
OncoCyte Initiates Search for New Independent Director
Nov 29, 2017 21:10 pm UTC| Business
ALAMEDA, Calif., Nov. 29, 2017 -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced that it has initiated a search for a new...
Univest Announces Proposed Public Offering of Common Stock
Nov 29, 2017 21:05 pm UTC| Business
SOUDERTON, Pa., Nov. 29, 2017 -- Univest Corporation of Pennsylvania (NASDAQ:UVSP) (“Univest” or the “Corporation”), parent company of Univest Bank and Trust Co. (the “Bank”), announced today that it has commenced an...
Adamis Pharmaceuticals Submits Prior Approval Supplement to FDA for the Pediatric Version of Symjepi
Nov 29, 2017 21:05 pm UTC| Business
SAN DIEGO, Nov. 29, 2017 -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today announced the submission of a prior approval supplement to the U.S. Food and Drug Administration (“FDA”) for a pediatric version...
Nov 29, 2017 21:05 pm UTC| Business
SANTA CLARA, Calif., Nov. 29, 2017 -- Adesto Technologies (NASDAQ:IOTS), a leading provider of application-specific, ultra-low power non-volatile memory products, today announced its EcoXiP™ family of products, paired...
Sabra Health Care REIT, Inc. to Participate in Non-Deal Roadshow
Nov 29, 2017 21:05 pm UTC| Business
IRVINE, Calif., Nov. 29, 2017 -- Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP) announced today that Rick Matros, the company’s Chairman and Chief Executive Officer, Harold Andrews, the company’s Chief...
TRACON Doses First Patient in Phase 1b Study of TRC105 with Opdivo® in Patients with Lung Cancer
Nov 29, 2017 21:05 pm UTC| Business
SAN DIEGO, Nov. 29, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...